Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Examining the prevalence of hepatic steatosis and advanced fibrosis using non-invasive measures across Canada: A national estimate using the Canadian Health Measures Survey (CHMS) from 2009-2019
Jacob Romano; Jessica Burnside; Giada Sebastiani; Alnoor Ramji; Keyur Patel; Mark Swain; Sahar Saeed;
10.1016/j.aohep.2024.101757
Blood pressure stratification for predicting liver fibrosis risk in metabolic dysfunction associated fatty liver disease
Jing Liu; Haifeng Lv; Jie Wang; Qianru Zhu; Gongying Chen; Yanming Jiang; Ke Zhao; Li Shao; Junping Shi; Xiaoben Pan;
Ann Hepatol. 2023;28:
Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease
Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;
10.1016/j.aohep.2024.101589